SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Behavioral Neurology Consultation — Frederick Law Olmsted
| Patient | Frederick Law Olmsted |
|---|
| Date of birth | 1953-04-26 |
|---|
| Identifiers | MRN HR-NI022-SYN; SSN (made up) 000-22-5519 |
|---|
| Document date | 2026-06-02 |
|---|
| Author | Marguerite Osei, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Reason for Referral
Progressive memory loss over about two years in a 73-year-old landscape architect who has had to step back from his practice. Please confirm whether this is dementia or mild cognitive impairment, advise on the likely type and on biomarker testing, advise on treatment, and advise on driving. [S]
Urgency: Routine, within four weeks, on the same day as his results visit. [S]
Questions for the consultant:
- Does he meet criteria for dementia rather than mild cognitive impairment, and at what stage?
- What type of dementia is most likely, and do the MRI findings point to one?
- Would blood, CSF, or amyloid PET biomarkers help, and is he a candidate for anti-amyloid therapy?
- Do you recommend a cholinesterase inhibitor, and with what monitoring?
- Is it safe for him to keep driving, and what other safety steps do you advise?
- How often should he be followed, and by whom?
History of Present Illness
Mr. Olmsted, a 73-year-old landscape architect, is seen with his caregiver at the request of Dr. Calder for about two years of progressive memory loss. He repeats questions, loses track of correspondence and plans, and needs reminders for appointments; he stepped back from his practice this year. His caregiver now manages his medicines and bill paying. He drives short familiar routes and took a wrong turn near home this month. He has no visual hallucinations, fluctuations in alertness, acting out of dreams, tremor, falls, gait change, urinary incontinence, change in personality or social conduct, or difficulty finding words beyond names. He is irritable and apathetic at times and sad about leaving his work, without thoughts of self-harm. He stopped his glass of wine with dinner a month ago and takes no medicines. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
- Frederick Law Olmsted was born in Hartford, Connecticut, on April 26, 1822. [D]
- Olmsted ceased active practice in 1895, a victim of failing memory and vitality; later accounts say dementia, or senility, forced his retirement, and his sons took over the firm. [D]
- Olmsted, who had chosen the Belmont site of McLean Hospital in 1872, was admitted there as a patient at the end of his life and spent his last five years there, until his death in 1903. [D]
- His McLean Hospital medical record is sealed, and the cause of his decline is not known. [D]
- Any specific type of dementia (for example Alzheimer's disease or vascular dementia) is a retrospective interpretation; the cited sources say only failing memory, senility, and dementia. [R]
- A psychiatrist has argued retrospectively that losses in his childhood, beginning with his mother's death when he was a young child, left him with post-traumatic stress, and that his late illness made it worse. [R]
- In 1863, exhausted and ill after overwork as head of the U.S. Sanitary Commission, Olmsted resigned. [D]
2 later historical claims are omitted because they describe events after the index age. See the teaching note.
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Medications
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|
| Donepezil 5 mg oral tablet, one tablet by mouth each morning | One tablet by mouth each morning with breakfast | Oral route | 2026-06-02 to 2026-08-04 | completed | S |
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| Mild dementia (major neurocognitive disorder), progressive, amnestic-predominant with executive difficulty, type undetermined; CDR global 1 | active | confirmed |
F03.A0 | S — Synthetic modern coding of his documented failing memory; the cause is unknown, so the type is left unspecified. Stage and scores are synthetic. |
| Progressive memory loss over about two years with decline in managing his work and affairs, under evaluation for dementia or mild cognitive impairment | resolved | confirmed |
R41.3 | S — Synthetic presenting concern at the index visit, superseded by the dementia diagnosis at the four-week visit; the failing memory is documented (D). |
Physical Exam
Vital signs recorded on 2026-06-02; see the referring visit's Vital Signs section. [S]
| System | Finding |
|---|
| General | Alert, courteous, and articulate; repeats one question during the visit |
| Cognition | Oriented to person and place, not to date; recalls 1 of 3 words after five minutes, helped partly by cues; reduced letter fluency; clock drawing with misplaced numbers; naming, repetition, and comprehension intact; no neglect or apraxia |
| Mood and behavior | Mildly flat; appropriate and socially engaged; no disinhibition |
| Cranial nerves | Full eye movements, including vertical gaze; face symmetric |
| Motor | Normal tone; no rest tremor, rigidity, or bradykinesia; strength normal |
| Reflexes and sensation | Reflexes symmetric; plantar responses flexor; no primitive reflexes; sensation intact |
| Gait | Normal stride, base, and arm swing; no magnetic or shuffling quality; turns steadily |
Assessment
- Mild dementia, type undetermined (F03.A0). Mild dementia (CDR global 1, FAST stage 4) rather than mild cognitive impairment, because his loss of independence in finances, medicines, and planning reflects cognitive decline. The tests have excluded thyroid disease, vitamin B12 and folate deficiency, and metabolic causes, and the MRI excludes stroke, tumor, subdural hematoma, and hydrocephalus. [S]
- Type of dementia. The gradual amnestic onset with executive difficulty and mild medial temporal atrophy fits Alzheimer's disease best, but the atrophy is within the range seen in some older adults without it, and mixed causes are common at his age. The small-vessel change is too slight to explain dementia. There are no core features of dementia with Lewy bodies, no behavioral or language features of frontotemporal dementia, and no gait or urinary features of normal pressure hydrocephalus. Without biomarkers the type cannot be established, and it is recorded as undetermined. [S]
- Biomarkers and anti-amyloid therapy. A blood p-tau217 test, CSF, or amyloid PET could show whether Alzheimer's pathology is present, and with mild dementia he could be assessed for anti-amyloid therapy after APOE genotyping. After discussion he does not want infusions with repeated MRI monitoring and their risk of brain swelling or bleeding, and the result would not change the rest of his care. He and his caregiver chose not to test now; the option remains open. [S]
- Cholinesterase inhibitor. With Alzheimer's disease the most likely cause, a trial of donepezil is reasonable. His pulse is 70 with no fainting or conduction symptoms, so no ECG is needed first. [S]
- Driving and safety. At CDR 1 with a recent wrong turn, his crash risk is high, and stopping driving is advised over an on-road test. There are no firearms at home. He has not wandered. [S]
Data reviewed: Dr. Calder's assessment four weeks ago: MoCA 19 with its item profile, Katz ADL, Lawton IADL, NPI-Q, PHQ-9 6, and Timed Up and Go; blood count, metabolic panel, albumin, ALT, vitamin B12, folate, and TSH, all normal; the brain MRI images and report from two weeks ago; and today's pulse and blood pressure. [S]
Plan of Treatment
- Start donepezil 5 mg each morning, and increase to 10 mg after four to eight weeks if tolerated; check pulse, fainting, nausea, diarrhea, weight, and sleep at each visit. [S]
- Avoid anticholinergic and sedating drugs: diphenhydramine and other first-generation antihistamines, over-the-counter PM sleep aids, bladder antispasmodics, benzodiazepines, and sleeping pills. [S]
- Stop driving now; he agreed today. [S]
- Keep the home free of firearms; wear a medical identification bracelet; caregiver to supervise medicines and oversee finances; home safety checklist. [S]
- No biomarker testing or anti-amyloid therapy now, by his choice; revisit if his wishes change. [S]
- No repeat imaging or further laboratory tests unless the course becomes rapid or atypical; no syphilis or HIV testing without risk factors. [S]
- Caregiver support: Zarit Burden Interview, education, adult day program and respite, and the Alzheimer's Association helpline. [S]
- Advance care planning soon, while he can take full part. [S]
- Primary care reviews every three months for the first year on the CMID schedule, with MoCA, ADL and IADL, and CDR stage yearly. [S]
- Discussed with Dr. Calder, who sees him the same day. The diagnosis, its uncertainty, and the plan were explained plainly to Mr. Olmsted, as he asked, and to his caregiver; he agreed to the plan and to stop driving. [S]
- Follow-up: Behavioral neurology review in one year, or sooner for a faster decline, hallucinations, fluctuations, falls, or new behavioral symptoms. [S]